| Fiscal Year End | Company Status | Exempt Flag |
| December 31 | Delist | N |
|
|
|
|
|
| Incorporation Locations |
| Inc. Date | Expiry Date | Country | Region | Description |
| 4/Feb/1997 | 13/May/2015 | Canada | Alberta | |
|
|
| Exchange Filing Office |
| Location |
| (not available) |
|
|  |
| Business Type(s) |
| Primary/Secondary | Business Type | Details |
| Primary
| *Biotechnology Research and Development Laboratories or Services
| Biotechnology company focused on designing novel cancer drugs.
|
|
| *Scientific Research And Development Services
| Biotech research specializing in gap junction intercellular communications and three-dimensional cell-cultures.
|
|
| *Capital Pool Company
| (not available)
|
|
|
| Securities |
| Symbol | Security Name | Market | Status |
| *GAP.H | *PharmaGap Inc. | TSX Venture | DELIST |
| *GAP | *PharmaGap Inc. | TSX Venture | DELIST |
| *SEB | *Sebring Resources Ltd | TSX Venture | DELIST |
| *SEB | *Sebring Resources Ltd | ASE | DELIST |
|
|
| Name History | From | To |
| *PharmaGap Inc. | 23/Apr/2002 | 13/May/2015 |
| *Sebring Resources Ltd. | 4/Feb/1997 | 22/Apr/2002 |
|
|
| Company Facts Reconciliation |
| Subject | Date Returned |
| Spring 2015 CFR | Not Received |
|
|
|
|
|
